Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation

被引:128
作者
Gutcher, Ilona
Urich, Eduard
Wolter, Karina
Prinz, Marco
Becher, Burkhard [1 ]
机构
[1] Univ Zurich, Neuroimmunol Unit, Neurol Clin, CH-8057 Zurich, Switzerland
[2] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany
关键词
D O I
10.1038/ni1377
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper type 1 (T(H)1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As interleukin 18 (IL-18) is a cofactor with IL-12 in promoting T(H)1 cell development, we examined the function of IL-18 and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice, IL-18-deficient mice were susceptible to experimental autoimmune encephalomyelitis. In contrast, IL-18R alpha-deficient mice were resistant to experimental autoimmune encephalomyelitis, indicating involvement of an IL-18R alpha ligand other than IL-18 with encephalitogenic properties. Moreover, engagement of IL-18R alpha on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus, IL-18 and T(H)1 cells are dispensable, whereas IL-18R alpha and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.
引用
收藏
页码:946 / 953
页数:8
相关论文
共 52 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
    Aggarwal, S
    Ghilardi, N
    Xie, MH
    de Sauvage, FJ
    Gurney, AL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1910 - 1914
  • [3] Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
    Becher, B
    Durell, BG
    Noelle, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) : 493 - 497
  • [4] IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis
    Becher, B
    Durell, BG
    Noelle, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) : 1186 - 1191
  • [5] The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
    Becher, B
    Durell, BG
    Miga, AV
    Hickey, WF
    Noelle, RJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) : 967 - 974
  • [6] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [7] Boraschi Diana, 1998, European Cytokine Network, V9, P205
  • [8] Immunopathogenesis of collagen arthritis
    Brand, DD
    Kang, AH
    Rosloniec, EF
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 25 (01): : 3 - 18
  • [9] REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS
    CHEN, YH
    KUCHROO, VK
    INOBE, J
    HAFLER, DA
    WEINER, HL
    [J]. SCIENCE, 1994, 265 (5176) : 1237 - 1240
  • [10] Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
    Chu, CQ
    Wittmer, S
    Dalton, DK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 123 - 128